Multilayered Regulation and Clonal Dynamics of the miR-15a/16-1 Cluster in Chronic Lymphocytic Leukemia with del(13q)
Cells · 14.11.2026 · 15 (22) · 2086
DOI: 10.3390/cells15222086 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 14.11.2026. Verfasst von Giulia Ripari und 5 weiteren Autor:innen. Die Arbeit nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ricerca Finalizzata 2024.
Abstract (Originalsprache)
Chronic lymphocytic leukemia (CLL) is a genetically heterogeneous B-cell malignancy in which deletion of chromosome 13q14 [del(13q)] represents the most frequent cytogenetic abnormality. Although isolated del(13q) is traditionally associated with a favourable prognosis, its biological and clinical consequences depend on its underlying genomic context. The DLEU2/miR-15a/16-1 locus within 13q14 represents a key non-coding tumour-suppressive regulatory axis. This review examines the mechanisms underlying miR-15a/16-1 deregulation in CLL and their implications for leukemic biology, clonal evolution, and therapeutic vulnerability. A narrative review of the literature was conducted, focusing on studies addressing the genomic architecture of the 13q14 locus, transcriptional, epigenetic, and post-transcriptional regulation of miR-15a/16-1, validated downstream targets, and the clinical relevance of deletion size, allelic status, deletion burden, and co-occurring cytogenetic lesions. miR-15a/16-1 deregulation results from multilayered mechanisms, including structural heterogeneity of del(13q), altered DLEU2 promoter activity, epigenetic repression, impaired miRNA processing, and subclonal evolution. Reduced cluster expression promotes derepression of key targets involved in apoptosis resistance, cell-cycle progression, and pro-survival signaling, including BCL2, MCL1, CCND1, CDK6, and components of the TP53 and mTOR pathways. The biological effects of del(13q) are further shaped by deletion boundaries, RB1 involvement, clone size, allelic status, and coexisting genomic alterations, including trisomy 12 (+12). The DLEU2/miR-15a/16-1 locus should be considered a dynamic genomic determinant rather than a static favourable-risk lesion. Integrative high-resolution and single-cell approaches may improve the characterization of 13q14 abnormalities and refine biologically informed risk stratification and therapeutic strategies in CLL.
Förderung
- Ricerca Finalizzata 2024
Zitieren
APA
Ripari, G., Atene, C. G., Cordella, S., Potenza, L., Luppi, M., & Marasca, R. (2026). Multilayered Regulation and Clonal Dynamics of the miR-15a/16-1 Cluster in Chronic Lymphocytic Leukemia with del(13q). Cells, 15(22), 2086. https://doi.org/10.3390/cells15222086
Vancouver
Ripari G, Atene CG, Cordella S, Potenza L, Luppi M, Marasca R. Multilayered Regulation and Clonal Dynamics of the miR-15a/16-1 Cluster in Chronic Lymphocytic Leukemia with del(13q). Cells. 2026;15(22):2086. doi:10.3390/cells15222086
BibTeX
@article{Ripari2026,
author = {Ripari, Giulia and Atene, Claudio Giacinto and Cordella, Stefano and Potenza, Leonardo and Luppi, Mario and Marasca, Roberto},
title = {Multilayered Regulation and Clonal Dynamics of the miR-15a/16-1 Cluster in Chronic Lymphocytic Leukemia with del(13q)},
journal = {Cells},
year = {2026},
volume = {15},
number = {22},
pages = {2086},
doi = {10.3390/cells15222086}
}
EUVIMED